Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.42
-0.87-26.44%
At close: -
$2.44
0.020.83%
After Hours: Jun 20, 7:59 PM EDT
Comments
Loading...
Galectin Therapeutics Stock Price, Quotes and Forecasts
GALTNASDAQ
Galectin Therapeutics (GALT) Forecast
NewsEarningsGalectin Therapeutics (GALT) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Galectin Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:GALT | Benzinga
Explore Galectin Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for GALT.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Galectin Therapeutics (GALT) stock?
You can purchase shares of Galectin Therapeutics (NASDAQ:GALT) through any online brokerage.
Who are Galectin Therapeutics (GALT) competitors?
Other companies in Galectin Therapeutics’s space includes: Bright Minds Biosciences (NASDAQ:DRUG), 4D Molecular Therapeutics (NASDAQ:FDMT), ProQR Therapeutics (NASDAQ:PRQR), Monopar Therapeutics (NASDAQ:MNPR) and Tevogen Bio Holdings (NASDAQ:TVGN).
What is the forecast, or price target, for Galectin Therapeutics (GALT) stock?
Galectin Therapeutics has a consensus price target of $6.00.
What is the current price for Galectin Therapeutics (GALT)?
The stock price for Galectin Therapeutics (NASDAQ: GALT) is $2.44 last updated June 20, 2025 at 7:59 PM EDT.
Does Galectin Therapeutics (GALT) pay a dividend?
There are no upcoming dividends for Galectin Therapeutics.
When is Galectin Therapeutics (NASDAQ:GALT) reporting earnings?
Galectin Therapeutics’s Q2 earnings are confirmed for Tuesday, August 12, 2025.
Is Galectin Therapeutics (GALT) going to split?
There is no upcoming split for Galectin Therapeutics.
What sector and industry does Galectin Therapeutics (GALT) operate in?
Galectin Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
